PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinomachemotherapyRetlirafusp alfabintrafusp alfaSHR-1701
…pproved in China on January 7, 2026 for first-line treatment of PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma with chemotherapy. This first-in-class milestone revisits a key…